Evidence map›Paper›PMID 39458575›Full record

ArticlePharmaceutics2024

Inhibition of Angiogenesis and Effect on Inflammatory Bowel Disease of Ginsenoside Rg3-Loaded Thermosensitive Hydrogel.

Yiqiong Xie, Ying Ma, Lu Xu, Hongwen Liu, Weihong Ge, Baojuan Wu, Hongjue Duan, Hongmei Zhang, Yuping Fu, Hang Xu and 3 more

Abstract read
In one paragraph

Article in Pharmaceutics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Yiqiong XieDepartment of Pharmacy, Nanjing Drum Tower Hospital Clinical College of Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing 210008, China.ORCID 0000-0001-8485-3120
Ying MaJiangsu Institute for Food and Drug Control, Nanjing 210008, China.
Lu XuDepartment of Pharmacy, Nanjing Drum Tower Hospital Clinical College of Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing 210008, China.
Hongwen LiuDepartment of Gastroenterology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing 210008, China.
Weihong GeDepartment of Pharmacy, Nanjing Drum Tower Hospital Clinical College of Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing 210008, China.
Baojuan WuDivision of Breast Surgery, Department of General Surgery, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing 210008, China.
Hongjue DuanNanjing Medical Center for Clinical Pharmacy, Nanjing 210008, China.
Hongmei ZhangDivision of Breast Surgery, Department of General Surgery, Nanjing Drum Tower Hospital Clinical College of Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing 210008, China.
Yuping FuDivision of Breast Surgery, Department of General Surgery, Nanjing Drum Tower Hospital Clinical College of Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing 210008, China.
Hang XuSchool of Pharmacy, Faculty of Medicine, Macau University of Science and Technology, Macau SAR, China.
Yuxiang SunInstitute of Translational Medicine, Medical College, Yangzhou University, Yangzhou 225001, China.
Zhou HanDepartment of Pharmacy, Nanjing Drum Tower Hospital Clinical College of Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing 210008, China.
Yun ZhuDepartment of Pharmacy, Nanjing Drum Tower Hospital Clinical College of Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing 210008, China.ORCID 0000-0002-1299-6509

Funding

Jiangsu Provincial Double-Innovation Doctor Program PF-302-2021Nanjing Special Foundation for Health Science and Technology Development YKK23104National Natural Science Foundation of China 82102917special Fund for Clinical Research of Wu Jieping Medical Foundation No.320.6750.2021-02-140
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

angiogenesisdrug delivery systemginsenoside Rg3inflammatory bowel diseasethermosensitive hydrogel

Identifiers

PMID39458575
PMCPMC11509886

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.